...
【24h】

Salt: its role in chronic kidney disease.

机译:盐:其在慢性肾脏疾病中的作用。

获取原文
获取原文并翻译 | 示例

摘要

Few controversies in medicine have such a long history as that of whether salt is identifiably dangerous or not dangerous. The most common reported association between excess dietary salt intake and clinical outcome has been in the field of hypertension, but dietary sodium intake mediates effects that go far beyond, and are independent of, extracellular fluid expansion and elevation in blood pressure. For nephrologists, clinical trials that demonstrate no negative outcome of a high salt diet in the general population are thus not particularly assuasive, because patients with chronic kidney disease (CKD) represent an entity that is by no means comparable to the general population. This review takes a look at the challenges associated with salt balance in CKD patients (particularly at K/DOQI stage 5), followed by a summary of current concepts believed to play a part in salt-mediated pathophysiology, and the conclusion, based on the present state of scientific knowledge, that it appears advisable to advocate low dietary salt intake in this patient population.
机译:很少有医学争论具有悠久的历史,例如盐是否可以确定地危险或不危险。饮食中盐摄入过多与临床结果之间的最常见关联是高血压,但饮食中钠摄入的介导作用远远超出且不依赖于细胞外液的扩张和血压升高。对于肾病学家来说,临床试验证明在普通人群中没有高盐饮食没有负面结果,因此并不是特别令人信服的,因为患有慢性肾脏疾病(CKD)的患者所代表的实体绝不能与普通人群相比。这篇综述着眼于与CKD患者的盐平衡有关的挑战(特别是在K / DOQI 5期),然后总结了目前认为在盐介导的病理生理学中发挥作用的概念,并得出结论。目前的科学知识水平,建议在此患者人群中倡导低饮食盐摄入是明智的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号